Gene: RAB40B
Official Full Name: RAB40B, member RAS oncogene familyprovided by HGNC
Gene Summary: The protein encoded by this gene has similarity to a yeast protein which suggests a role of the gene product in regulating secretory vesicles. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31359 | RAB40B Knockout cell line (HeLa) | Human | RAB40B | 1:3~1:6 | Negative | Online Inquiry |
KO31360 | RAB40B Knockout cell line (HCT 116) | Human | RAB40B | 1:2~1:4 | Negative | Online Inquiry |
KO31361 | RAB40B Knockout cell line (HEK293) | Human | RAB40B | 1:3~1:6 | Negative | Online Inquiry |
KO31362 | RAB40B Knockout cell line (A549) | Human | RAB40B | 1:3~1:4 | Negative | Online Inquiry |
RAB40B Gene Knockout Cell Lines are specialized cellular models designed for the study of the RAB40B gene, which plays a critical role in intracellular trafficking and signal transduction pathways. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines exhibit a complete knockout of the RAB40B gene, allowing researchers to investigate its biological functions and implications in various cellular processes. The knockout mechanism ensures that the specific protein encoded by the RAB40B gene is absent, enabling detailed analysis of pathways regulated by RAB40B and its influence on cellular behavior.
The primary function of the RAB40B gene involves its participation in the regulation of receptor-mediated endocytosis and the maturation of endosomal compartments. Its absence in these knockout cell lines facilitates a clearer understanding of cellular trafficking abnormalities that might underlie pathologies, such as neurodegenerative diseases and cancer. The research applications extend to drug discovery and testing, as RAB40B’s role in modulating responses in specific signaling pathways can lead to the identification of novel therapeutic targets.
RAB40B Gene Knockout Cell Lines present significant advantages over traditional cell models. Their genetic modification eliminates variability linked to endogenous expression levels often found in wild-type cells, allowing for precise dose-response studies and the evaluation of potential pharmacological agents in a controlled environment. Additionally, these models are compatible with various high-throughput screening methods, making them ideal for expansive research endeavors.
Researchers and clinicians seeking to elucidate the molecular underpinnings of diseases or optimize therapeutic strategies will find immense value in these knockout cell lines. They offer a robust platform for advancing fundamental biological knowledge and fostering innovative clinical applications.
Our company prides itself on its commitment to quality and innovation in biological research tools. With a solid foundation in genetic engineering and a dedication to enhancing scientific exploration, we provide high-quality knockout cell lines that are meticulously validated for reproducibility and performance, empowering researchers to achieve their scientific goals with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.